Cargando…
The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa
INTRODUCTION: The extensive drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) causes a range of infections with high mortality rate, which inflicts additional costs on treatment. The use of nano-biotechnology-based methods in medicine has opened a new perspective against drug-resistant bac...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518771/ https://www.ncbi.nlm.nih.gov/pubmed/33061358 http://dx.doi.org/10.2147/IJN.S260520 |
_version_ | 1783587449154306048 |
---|---|
author | Shahbandeh, Mahsa Taati Moghadam, Majid Mirnejad, Reza Mirkalantari, Shiva Mirzaei, Mehrnaz |
author_facet | Shahbandeh, Mahsa Taati Moghadam, Majid Mirnejad, Reza Mirkalantari, Shiva Mirzaei, Mehrnaz |
author_sort | Shahbandeh, Mahsa |
collection | PubMed |
description | INTRODUCTION: The extensive drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) causes a range of infections with high mortality rate, which inflicts additional costs on treatment. The use of nano-biotechnology-based methods in medicine has opened a new perspective against drug-resistant bacteria. The aim of this study was to evaluate the effectiveness of the AgNO3 nanoparticles alone and conjugated with imipenem (IMI) to combat extensively drug-resistant P. aeruginosa. METHODS: Antibiotic susceptibility was carried out using disc diffusion method. Detection of different resistant genes was performed using standard polymerase chain reaction (PCR). The chemically synthesized AgNO(3) particles were characterized using scanning electron microscope (SEM), dynamic light scattering (DLS) and X-ray diffraction (XRD) methods. Fourier transform infrared spectroscopy (FTIR) was accomplished to confirm the binding of AgNO(3) with IMI. The microdilution broth method was used to obtain minimum inhibitory concentration (MIC) of AgNO(3) and IMI-conjugated AgNO(3). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was carried out on L929 cell line to study the cytotoxicity of nanoparticles. The data were analyzed by Eta correlation ratio and chi-square (X(2)) test. RESULTS: Analysis of the antibiotic resistance pattern showed that 12 (24%) isolates were XDR, and MIC values of IMI were between 64 and 128 μg/mL. Frequency of SHV, TEM, CTX M, IMP, VIM, OPR, SIM, SPM, GIM, NDM, VEB, PER, KPC, OXA, intI, intII, and intIII genes were 29 (58%), 26 (52%), 26 (52%), 32 (64%), 23 (46%), 43 (86%), 3 (6%), 6 (12%), 3 (6%), 4 (8%), 7 (14%), 6 (12%), 18 (36%), 4 (8%), 19 (38%), 16 (32%), and 2 (4%), respectively. The XRD, SEM, DLS, and FTIR analysis confirmed the synthesis of AgNO(3) nanoparticles and their conjugation with IMI. The AgNO(3) nanoparticles had antimicrobial activity, and their conjugation with IMI showed enhanced effectiveness against XDR isolates. The synthesized AgNO(3) showed no cytotoxic effects. CONCLUSION: The results suggest that IMI-conjugated AgNO(3) has a strong potency as a powerful antibacterial agent against XDR P. aeruginosa. |
format | Online Article Text |
id | pubmed-7518771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75187712020-10-14 The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa Shahbandeh, Mahsa Taati Moghadam, Majid Mirnejad, Reza Mirkalantari, Shiva Mirzaei, Mehrnaz Int J Nanomedicine Original Research INTRODUCTION: The extensive drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) causes a range of infections with high mortality rate, which inflicts additional costs on treatment. The use of nano-biotechnology-based methods in medicine has opened a new perspective against drug-resistant bacteria. The aim of this study was to evaluate the effectiveness of the AgNO3 nanoparticles alone and conjugated with imipenem (IMI) to combat extensively drug-resistant P. aeruginosa. METHODS: Antibiotic susceptibility was carried out using disc diffusion method. Detection of different resistant genes was performed using standard polymerase chain reaction (PCR). The chemically synthesized AgNO(3) particles were characterized using scanning electron microscope (SEM), dynamic light scattering (DLS) and X-ray diffraction (XRD) methods. Fourier transform infrared spectroscopy (FTIR) was accomplished to confirm the binding of AgNO(3) with IMI. The microdilution broth method was used to obtain minimum inhibitory concentration (MIC) of AgNO(3) and IMI-conjugated AgNO(3). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was carried out on L929 cell line to study the cytotoxicity of nanoparticles. The data were analyzed by Eta correlation ratio and chi-square (X(2)) test. RESULTS: Analysis of the antibiotic resistance pattern showed that 12 (24%) isolates were XDR, and MIC values of IMI were between 64 and 128 μg/mL. Frequency of SHV, TEM, CTX M, IMP, VIM, OPR, SIM, SPM, GIM, NDM, VEB, PER, KPC, OXA, intI, intII, and intIII genes were 29 (58%), 26 (52%), 26 (52%), 32 (64%), 23 (46%), 43 (86%), 3 (6%), 6 (12%), 3 (6%), 4 (8%), 7 (14%), 6 (12%), 18 (36%), 4 (8%), 19 (38%), 16 (32%), and 2 (4%), respectively. The XRD, SEM, DLS, and FTIR analysis confirmed the synthesis of AgNO(3) nanoparticles and their conjugation with IMI. The AgNO(3) nanoparticles had antimicrobial activity, and their conjugation with IMI showed enhanced effectiveness against XDR isolates. The synthesized AgNO(3) showed no cytotoxic effects. CONCLUSION: The results suggest that IMI-conjugated AgNO(3) has a strong potency as a powerful antibacterial agent against XDR P. aeruginosa. Dove 2020-09-21 /pmc/articles/PMC7518771/ /pubmed/33061358 http://dx.doi.org/10.2147/IJN.S260520 Text en © 2020 Shahbandeh et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Shahbandeh, Mahsa Taati Moghadam, Majid Mirnejad, Reza Mirkalantari, Shiva Mirzaei, Mehrnaz The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa |
title | The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa |
title_full | The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa |
title_fullStr | The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa |
title_full_unstemmed | The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa |
title_short | The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa |
title_sort | efficacy of agno3 nanoparticles alone and conjugated with imipenem for combating extensively drug-resistant pseudomonas aeruginosa |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518771/ https://www.ncbi.nlm.nih.gov/pubmed/33061358 http://dx.doi.org/10.2147/IJN.S260520 |
work_keys_str_mv | AT shahbandehmahsa theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT taatimoghadammajid theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT mirnejadreza theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT mirkalantarishiva theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT mirzaeimehrnaz theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT shahbandehmahsa efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT taatimoghadammajid efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT mirnejadreza efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT mirkalantarishiva efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa AT mirzaeimehrnaz efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa |